Studies in colorectal carcinoma have found high c-Myb expression to correlate with poor prognosis [10], and more recently the fusion of c-Myb and the transcription factor NFIB has been reported as a potential “hallmark” of adenoid cystic carcinomas [11]. The gene discussed is MYB; the disease is colorectal carcinoma.